The association of sclerostin with chronic inflammation has been suggested because several inflammatory cytokines stimulate sclerostin expression in osteocytes under pathological conditions, including obesity, diabetes, and CVD [[156], [157], [158]]. This evidence concerns the gene SOST and obesity due to melanocortin 4 receptor deficiency.